
CJC-1295 (No DAC)
5mg · Lyophilized Powder
$60.00 CAD
CJC-1295 (No DAC) is a modified 29-amino acid analogue of growth hormone-releasing hormone (GHRH) that stimulates pulsatile growth hormone release from the anterior pituitary. Without the Drug Affinity Complex, it has a shorter half-life of approximately 30 minutes, preserving the natural pulsatile pattern of GH secretion rather than producing continuous baseline elevation. Human studies demonstrate sustained, dose-dependent increases in both GH and IGF-1 following subcutaneous administration.
Research Applications
Commonly paired
CJC-1295 (No DAC) and Ipamorelin are frequently dosed together — complementary GHRH/GHRP mechanisms for growth-hormone pulse research.
All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
Customer Reviews
Create a free account to leave a review. Takes 30 seconds.
Frequently Asked Questions — CJC-1295 (No DAC)
Complete your stack

Tesamorelin
Growth hormone optimisation through natural pulsatile release
View Protocol →CJC-1295 (DAC)
Extended half-life GHRH analogue for sustained GH elevation
View Protocol →CJC-1295 / Ipamorelin Blend
Synergistic dual-pathway GH secretagogue blend
View Protocol →Ipamorelin
Selective GH secretagogue via ghrelin receptor activation
View Protocol →